OppenheimerFunds’s BioLife Solutions BLFS Stock Holding History

OppenheimerFunds’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,429	Closed	-$130K	–	1814
2018 Q2	$130K	Buy	+11,429	New	+$104K	﹤0.01%	1791

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds's BLFS Position: Q3 2018 in Review

OppenheimerFunds sold out of BioLife Solutions (BLFS) in Q3 2018, closing a stake of 11,429 shares — an estimated $130K sold.

OppenheimerFunds first reported a position in BLFS in Q2 2018 and held it in 1 quarter. The position peaked at $130K in Q2 2018. 54 funds tracked by Wall St. Rank hold BLFS as of Q3 2018.

OppenheimerFunds reported no remaining BioLife Solutions position as of Q3 2018 after selling out during the quarter.
OppenheimerFunds sold 11,429 BioLife Solutions shares in Q3 2018, an estimated $130K.
OppenheimerFunds first reported a position in BioLife Solutions in Q2 2018 and held it in 1 quarter.
OppenheimerFunds's BioLife Solutions position peaked at $130K in Q2 2018.
54 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2018.

Based on OppenheimerFunds's 13F filing for Q3 2018, filed 13 Nov 2018.